Pharmaceutical Technology® spoke with Tara Dougal, Event Director for Pharma at Informa Markets about what attendees at CPHI Frankfurt should expect this year.
Trends in Formulation October 2025 eBook
Non-parenteral alternatives for biologics remain a clinical imperative and a formidable challenge.
Michael Ritchie, chief commercial officer at Champions Oncology, explains what makes radiopharmaceuticals unique in the treatment of cancer.
The growing demand for liquid medicines is increasingly driven by the unique needs of several distinct patient groups, improving compliance in these demographics through flexible, palatable dosing options.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
AAPS PharmSci 360 2025: Instrumentation Innovation for Bioanalysis
2
Using A Streamlined Workflow to Identify Particulates in Biologic Drugs
3
Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge
4
From Lab to Patient: The Critical Role of Supply Chain & Distribution in the Life Sciences
5
